Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1996 Apr;11(4):229–236. doi: 10.1007/BF02642480

The common cold

Bennett Lorber 1,✉
PMCID: PMC7089473  PMID: 8744881

The content is available as a PDF (1.1 MB).

Footnotes

From the Section of Infectious Diseases, Temple University School of Medicine and Hospital, Philadelphia, Pennsylvania.

Dr. Lorber is a Thomas M. Durant Professor of Medicine.

References

  • 1.Gwaltney JM. Historical eras of the common cold. In: Root RK, Sande MA, editors. Viral Infections: Diagnosis, Treatment and Prevention. New York: Churchill Livingstone; 1993. pp. 1–13. [Google Scholar]
  • 2.Jackson GG, The Medical Research Council Common Cold Unit Harvard Hospital, Salisbury, Wilts, England. Rev Infect Dis. 1989;11:1020–1. doi: 10.1093/clinids/11.6.1020. [DOI] [PubMed] [Google Scholar]
  • 3.Andrewes CH. Adventures among viruses: III. The puzzle of the common cold. Rev Infect Dis. 1989;11:1022–8. doi: 10.1093/clinids/11.6.1022. [DOI] [PubMed] [Google Scholar]
  • 4.Gwaltney JM. The common cold. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995. pp. 561–6. [Google Scholar]
  • 5.Couch KB. The common cold: control? J Infect Dis. 1984;150:167–73. doi: 10.1093/infdis/150.2.167. [DOI] [PubMed] [Google Scholar]
  • 6.Monto AS, Ullman BM. Acute respiratory illness in an American community: the Tecumseh study. JAMA. 1974;227:164–9. doi: 10.1001/jama.227.2.164. [DOI] [PubMed] [Google Scholar]
  • 7.Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J Infect Dis. 1987;156:43–9. doi: 10.1093/infdis/156.1.43. [DOI] [PubMed] [Google Scholar]
  • 8.Rossmann MG, Arnold E, Erickson JW, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985;317:145–53. doi: 10.1038/317145a0. [DOI] [PubMed] [Google Scholar]
  • 9.Smith TJ, Kremer MJ, Luo M, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhabit uncoating. Science. 1986;133:1286–93. doi: 10.1126/science.3018924. [DOI] [PubMed] [Google Scholar]
  • 10.Winther B, Gwaltney JM, Mygind N. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 1986;156:1763–1763. doi: 10.1001/jama.256.13.1763. [DOI] [PubMed] [Google Scholar]
  • 11.Douglas RG, Lindgren KM, Couch RB. Exposure to cold environment and rhinovirus common cold. Failure to demonstrate effect. N Engl J Med. 1968;279:742–7. doi: 10.1056/NEJM196810032791404. [DOI] [Google Scholar]
  • 12.Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325:606–12. doi: 10.1056/NEJM199108293250903. [DOI] [PubMed] [Google Scholar]
  • 13.Stone AA, Bovbjerg DH, Neale JM, et al. Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life event. Beh Med. 1992;18:115–20. doi: 10.1080/08964289.1992.9936961. [DOI] [PubMed] [Google Scholar]
  • 14.Winther B. Effects on the nasal mucosa of upper respiratory viruses (common cold) Danish Med Bull. 1994;41:193–204. [PubMed] [Google Scholar]
  • 15.Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988;157:133–42. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
  • 16.Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990;161:120–3. doi: 10.1093/infdis/161.1.120. [DOI] [PubMed] [Google Scholar]
  • 17.Proud D, Gwaltney JM, Hendley JO, Dinarello CA, Gillis S, Schleimer RP. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis. 1994;169:1007–13. doi: 10.1093/infdis/169.5.1007. [DOI] [PubMed] [Google Scholar]
  • 18.Noah TL, Henderson FW, Wortman JA, et al. Nasal cytokine production in viral acute respiratory infection of childhood. J Infect Dis. 1995;171:584–92. doi: 10.1093/infdis/171.3.584. [DOI] [PubMed] [Google Scholar]
  • 19.Gwaltney JM, Hendley JO. Rhinovirus transmission. One if by air, two if by hand. Am J Epidemiol. 1978;107:357–61. doi: 10.1093/oxfordjournals.aje.a112555. [DOI] [PubMed] [Google Scholar]
  • 20.Hendley JO, Gwaltney JM. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev. 1988;10:242–58. [PubMed] [Google Scholar]
  • 21.Gwaltney JM, Moskalski PB, Hendley JO. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med. 1978;88:463–7. doi: 10.7326/0003-4819-88-4-463. [DOI] [PubMed] [Google Scholar]
  • 22.Dick EC, Jennings LC, Mink KA, Wartgow CD, Inhorn SL. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987;156:442–8. doi: 10.1093/infdis/156.3.442. [DOI] [PubMed] [Google Scholar]
  • 23.D’Alessio DJ, Meschievitz CK, Peterson JA, Dick CR, Dick EC. Short-duration exposure and the transmission of rhinovirus colds. J Infect Dis. 1984;150:189–94. doi: 10.1093/infdis/150.2.189. [DOI] [PubMed] [Google Scholar]
  • 24.Meschievitz CK, Schultz SB, Dick EC. A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J Infect Dis. 1984;150:195–200. doi: 10.1093/infdis/150.2.195. [DOI] [PubMed] [Google Scholar]
  • 25.Warshauer DM, Dick EC, Mandel AD, Flynn TC, Jerde RS. Rhinovirus infections in an isolated Antarctic station: transmission of the viruses and susceptibility of the population. Am J Epidemiol. 1989;129:319–40. doi: 10.1093/oxfordjournals.aje.a115136. [DOI] [PubMed] [Google Scholar]
  • 26.Foy HM, Cooney MK, Hall C, Malmgren J, Fox JP. Case-to-case intervals of rhinovirus and influenza virus infections in households. J Infect Dis. 1988;157:180–2. doi: 10.1093/infdis/157.1.180. [DOI] [PubMed] [Google Scholar]
  • 27.Ansari SA, Springthorpe VS, Sattar JA, Rivard S, Rahman M. Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol. 1991;29:2115–9. doi: 10.1128/jcm.29.10.2115-2119.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hendley JO, Wenzel RP, Gwaltney JM. Transmission of rhinovirus colds by self-inoculation. N Engl J Med. 1973;288:1361–4. doi: 10.1056/NEJM197306282882601. [DOI] [PubMed] [Google Scholar]
  • 29.Levandowski RA, Ou DW, Jackson GG. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis. 1986;153:743–8. doi: 10.1093/infdis/153.4.743. [DOI] [PubMed] [Google Scholar]
  • 30.Hsia J, Goldstein AL, Simon GL, Sztein M, Hayden FG. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis. 1990;162:591–7. doi: 10.1093/infdis/162.3.591. [DOI] [PubMed] [Google Scholar]
  • 31.Sung BS, Chonmaitree T, Broemeling LD, et al. Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin Infect Dis. 1993;17:38–42. doi: 10.1093/clinids/17.1.38. [DOI] [PubMed] [Google Scholar]
  • 32.Elkhatieb A, Hipskind G, Woerner D, Hayden FG. Middle ear abnormalities during natural rhinovirus colds in adults. J Infect Dis. 1993;168:618–21. doi: 10.1093/infdis/168.3.618. [DOI] [PubMed] [Google Scholar]
  • 33.Gwaltney JM, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25–30. doi: 10.1056/NEJM199401063300105. [DOI] [PubMed] [Google Scholar]
  • 34.Turner BW, Cail WS, Hendley JO, et al. Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds. J Allergy Clin Immunol. 1992;90:474–8. doi: 10.1016/0091-6749(92)90172-X. [DOI] [PubMed] [Google Scholar]
  • 35.Al-Nakib W, Tyrrell DA. Drugs against rhinoviruses. J Antimicrob Chemother. 1992;30:115–7. doi: 10.1093/jac/30.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hayden FG, Gwaltney JM. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. J Infect Dis. 1984;150:174–80. doi: 10.1093/infdis/150.2.174. [DOI] [PubMed] [Google Scholar]
  • 37.Samo TC, Greenberg SB, Couch RB, et al. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers. J Infect Dis. 1983;148:535–42. doi: 10.1093/infdis/148.3.535. [DOI] [PubMed] [Google Scholar]
  • 38.Farr BM, Gwaltney JM, Adams K, Hayden FG. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother. 1984;26:31–4. doi: 10.1128/aac.26.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hayden FG, Hipskind GJ, Woerner DH, et al. Intranasal pirodavir (R77, 975) treatment of rhinovirus colds. Antimicrob Agents Chemother. 1995;39:290–4. doi: 10.1128/aac.39.2.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Graham NMH, Burell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162:1277–82. doi: 10.1093/infdis/162.6.1277. [DOI] [PubMed] [Google Scholar]
  • 41.Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM. Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial. Ann Intern Med. 1992;117:37–41. doi: 10.7326/0003-4819-117-1-37. [DOI] [PubMed] [Google Scholar]
  • 42.Farr BM, Gwaltney JM, Handley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990;162:1173–7. doi: 10.1093/infdis/162.5.1173. [DOI] [PubMed] [Google Scholar]
  • 43.Howard JC, Kantner TR, Lilienfield LS, et al. Effectiveness of antihistamines in the symptomatic management of the common cold. JAMA. 1979;242:2414–7. doi: 10.1001/jama.242.22.2414. [DOI] [PubMed] [Google Scholar]
  • 44.Gaffey MJ, Kaiser DL, Hayden FG. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatr Infect Dis J. 1988;7:223–8. doi: 10.1097/00006454-198803000-00032. [DOI] [PubMed] [Google Scholar]
  • 45.Berkowitz RB, Tinkelman DG. Evaluation of oral terfenadine for treatment of the common cold. Ann Allergy. 1991;67:593–7. [PubMed] [Google Scholar]
  • 46.Gwaltney JM, Park J, Paul RA, Edelman D, O’Connor RR, Turner RB. A controlled trial of clemastine fumarate in experimental rhinovirus colds [abstract H41]. Abstracts of the 34th ICAAC. Washington, DC: American Society for Microbiology; 1994. [DOI] [PubMed] [Google Scholar]
  • 47.Borum P, Olsen L, Winther B, Mygind N. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Am Rev Respir Dis. 1981;123:418–20. doi: 10.1164/arrd.1981.123.4.418. [DOI] [PubMed] [Google Scholar]
  • 48.Akerlund A, Klint T, Olen L, Rundcrantz H. Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. J Laryngol Otol. 1989;103:743–6. doi: 10.1017/s0022215100109958. [DOI] [PubMed] [Google Scholar]
  • 49.Berkowitz RB, Connell JT, Dietz AJ, Greenstein JM, Tinkelman DG. The effectiveness of the nonsedating antihistamine loratidine plus pseudoephedrine in the symptomatic management of the common cold. Ann Allergy. 1989;63:336–9. [PubMed] [Google Scholar]
  • 50.Gwaltney JM. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. 1992;166:776–82. doi: 10.1093/infdis/166.4.776. [DOI] [PubMed] [Google Scholar]
  • 51.Pinnock CB, Graham NM, Mylvaganam A, Douglas RM. Relationship between milk intake and mucus production in adult volunteers challenged with rhinovirus-2. Am Rev Respir Dis. 1990;141:352–6. doi: 10.1164/ajrccm/141.2.352. [DOI] [PubMed] [Google Scholar]
  • 52.Tyrrell D, Barrow I, Arthur J. Local hyperthermia benefits natural and experimental common colds. BMJ. 1989;298:1280–3. doi: 10.1136/bmj.298.6683.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Macknin MI, Mathew S, Medendorp S. Effect of inhaling heated vapor in symptoms of the common cold. JAMA. 1990;264:989–91. doi: 10.1001/jama.264.8.989. [DOI] [PubMed] [Google Scholar]
  • 54.Forstall GJ, Macknin ML, Yen-Lieberman BR, Medendrop SV. Effect of inhaling heated vapor on symptoms of the common cold. JAMA. 1994;271:1109–11. doi: 10.1001/jama.271.14.1109. [DOI] [PubMed] [Google Scholar]
  • 55.Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. 1987;31:1183–7. doi: 10.1128/aac.31.8.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother. 1987;31:1263–5. doi: 10.1128/aac.31.8.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Godfrey JC, Sloane BC, Smith PS, Turco JN, Mercer N, Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. 1992;20:234–46. doi: 10.1177/030006059202000305. [DOI] [PubMed] [Google Scholar]
  • 58.Chalmers TC. Effects of ascorbic acid on the common cold. An evaluation of the evidence. Am J Med. 1975;58:532–6. doi: 10.1016/0002-9343(75)90127-8. [DOI] [PubMed] [Google Scholar]
  • 59.Panusarn C, Stanley ED, Dirda V, Rubenis M, Jackson GG. Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med. 1974;291:57–61. doi: 10.1056/NEJM197407112910201. [DOI] [PubMed] [Google Scholar]
  • 60.Hayden FG, Gwaltney JM. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. J Infect Dis. 1983;148:543–50. doi: 10.1093/infdis/148.3.543. [DOI] [PubMed] [Google Scholar]
  • 61.Douglas RM, Moore BW, Miles HB, et al. Prophylactic efficacy of alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med. 1986;314:65–70. doi: 10.1056/NEJM198601093140201. [DOI] [PubMed] [Google Scholar]
  • 62.Monto AS, Schwartz SA, Albrecht JK. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. Antimicrob Agents Chemother. 1989;33:387–90. doi: 10.1128/aac.33.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sperber SJ, Levine PA, Sorrentino JV, Riker DK, Hayden FG. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds. J Infect Dis. 1989;160:700–5. doi: 10.1093/infdis/160.4.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Schwartz AR, Toyo Y, Hornick RB, Tominaga S, Gleckman RA. Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man. J Infect Dis. 1973;128:500–5. doi: 10.1093/infdis/128.4.500. [DOI] [PubMed] [Google Scholar]
  • 65.Coulehan JL, Reisinger KS, Rogers KD, Bradley DW. Vitamin C prophylaxis in a boarding school. N Engl J Med. 1974;290:6–10. doi: 10.1056/NEJM197401032900102. [DOI] [PubMed] [Google Scholar]
  • 66.Coulehan JL, Eberhard S, Kapner L, Taylor F, Rogers K, Garry P. Vitamin C and acute illness in Navaho school children. N Engl J Med. 1976;295:973–7. doi: 10.1056/NEJM197610282951802. [DOI] [PubMed] [Google Scholar]
  • 67.Hayden GF, Hendley JO, Gwaltney JM. The effect of placebo and virucidal paper handkerchiefs on viral contamination of the hand and transmission of experimental rhinoviral infection. J Infect Dis. 1985;152:403–7. doi: 10.1093/infdis/152.2.403. [DOI] [PubMed] [Google Scholar]
  • 68.Dick EC, Hossain SU, Mink KA, et al. Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. J Infect Dis. 1986;153:352–6. doi: 10.1093/infdis/153.2.352. [DOI] [PubMed] [Google Scholar]
  • 69.Hayden GF, Deforest D, Hendley JO, Gwaltney JM. Inactivation of rhinovirus on human fingers by virucidal activity of glutaric acid. Antimicrob Agents Chemother. 1984;26:928–9. doi: 10.1128/aac.26.6.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Benchley R. Benchley—Or Else. New York: Harper and Brothers; 1947. How to avoid colds; pp. 164–6. [Google Scholar]

Articles from Journal of General Internal Medicine are provided here courtesy of Nature Publishing Group

RESOURCES